v3.26.1
Segment Information - Schedule of Significant Expense Categories of the Company’s Single Operating Segment (Details) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Significant Revenue and Expense Categories of the Company’s Single Operating Segment [Abstract]    
Clinical trial related service fee to related party (Note 5) $ 1,375,000 $ 1,375,000
Consulting fee 15,000 25,000
Stock-based compensation (Note 8) 146,714 159,095
Salary expense 128,764 129,711
Professional fee 398,133 285,090
Insurance expense 79,339 81,057
Other general and administrative fee 149,114 49,345
Loss before income tax 2,292,064 2,104,298
Income tax expense 13
Net loss $ 2,292,064 $ 2,104,311